• CONTACT
  • NEWS & MEDIA
  • UPCOMING EVENTS
  • Canady Helios Cold Plasma
  • Canady Hybrid Plasma
    • Canady Hybrid Plasma Technology
    • Canady Plasma XL 1000 Smart Electrosurgical Generator
    • Canady Hybrid Plasma™ Scalpel
    • Canady Plasma Probes
  • Our Treatment
  • Science of Plasma
  • About Us
    • Message From CEO
    • Mission/Vision
    • Management Team
    • Company Milestones
  • Our Patients
    • PATIENT FOCUS
    • Clinical Trial
Canady Cold Plasma Conversion System Treatment: An Effective Inhibitor of Cell Viability in Breast Cancer Molecular Subtypes

Canady Cold Plasma Conversion System Treatment: An Effective Inhibitor of Cell Viability in Breast Cancer Molecular Subtypes

by PVA_Admin | Aug 1, 2020 | Cold Plasma Publications, Publications

Canady Cold Plasma Conversion System Treatment: An Effective Inhibitor of Cell Viability in Breast Cancer Molecular Subtypes Xiaoqian Cheng, Saravana R. K. Murthy, Taisen Zhuang, Lawan Ly, Olivia Jones, Giacomo Basadonna, Michael Keidar, Yasmine Kanaan, and Jerome...

Scientific American Top Ten Emerging Technologies of 2019: Canady Cold Plasma

by PVA_Admin | Dec 20, 2019 | Cold Plasma Publications, Publications

Scientific American Top Ten Emerging Technologies of 2019: Canady Cold Plasma Mark Peplow PhD When a surgeon removes a tumor, some cancer cells may get left behind, threatening to seed another malignant growth. Researchers have just begun the first clinical trial of a...
Reduced Blood Loss With Use of Canady Hybrid Plasma Scalpel Compared With Bovie Electrocautery in the Resection of Soft-Tissue Sarcomas

Reduced Blood Loss With Use of Canady Hybrid Plasma Scalpel Compared With Bovie Electrocautery in the Resection of Soft-Tissue Sarcomas

by PVA_Admin | Dec 18, 2019 | Cold Plasma Publications, Publications

Reduced Blood Loss With Use of Canady Hybrid Plasma Scalpel Compared With Bovie Electrocautery in the Resection of Soft-Tissue Sarcomas Connor J. Wakefield, BS, Chris Culvern, MS, Matthew W. Colman, MD, Jerome Canady, MD, Steven Gitelis, MD, Alan T. Blank, MD, MS As...
A New Cold Plasma Jet: Performance Evaluation of Cold Plasma, Hybrid Plasma and Argon Plasma Coagulation

A New Cold Plasma Jet: Performance Evaluation of Cold Plasma, Hybrid Plasma and Argon Plasma Coagulation

by PVA_Admin | Sep 18, 2018 | Cold Plasma Publications, Publications

A New Cold Plasma Jet: Performance Evaluation of Cold Plasma, Hybrid Plasma and Argon Plasma Coagulation Lawan Ly, Sterlyn Jones, Alexey Shashurin, Taisen Zhuang, Warren Rowe III, Xiaoqian Cheng, Shruti Wigh, Tammey Naab, Michael Keidar, and Jerome Canady...
A New Cold Plasma Jet: Performance Evaluation of Cold Plasma, Hybrid Plasma and Argon Plasma Coagulation

Treatment of Triple-Negative Breast Cancer Cells with the Canady Cold Plasma Conversion System: Preliminary Results

by PVA_Admin | Sep 15, 2018 | Cold Plasma Publications, Publications

Treatment of Triple-Negative Breast Cancer Cells with the Canady Cold Plasma Conversion System: Preliminary Results Xiaoqian Cheng, Warren Rowe, Lawan Ly, Alexey Shashurin, Taisen Zhuang, Shruti Wigh,Giacomo Basadonna, Barry Trink, Michael Keidar, and Jerome Canady...
A New Cold Plasma Jet: Performance Evaluation of Cold Plasma, Hybrid Plasma and Argon Plasma Coagulation

The Canady Helios Cold Plasma Scalpel Significantly Decreases Viability in Malignant Solid Tumor Cells in a Dose-Dependent Manner

by PVA_Admin | Sep 7, 2018 | Cold Plasma Publications, Publications

The Canady Helios Cold Plasma Scalpel Significantly Decreases Viability in Malignant Solid Tumor Cells in a Dose-Dependent Manner Warren Rowe, Xiaoqian Cheng, Lawan Ly, Taisen Zhuang, Giacomo Basadonna, Barry Trink, Michael Keidar, and Jerome Canady Malignant solid...
« Older Entries
Next Entries »

Recent Posts

  • US Medical Innovations Secures FDA Clearance for Canady Helios Cold Plasma™ Ablation System
  • USMI TO DEBUT THE CANADY ROBOTIC AI SURGICAL SYSTEM AT THE FIRST GLOBAL SURGICAL ONCOLOGY SUMMIT JERUSALEM, ISRAEL JANUARY 2024
  • Groundbreaking Results Using Canady Helios™ Cold Plasma Treatment Published in MDPI Journal “Cancers”
  • The First Cold Atmospheric Plasma Phase I Clinical Trial for the Treatment of Advanced Solid Tumors: A Novel Treatment Arm for Cancer
  • USMI Receives FDA Approval for New Robotic Surgery Device – The Canady Flex RoboWrist™

Recent Comments

No comments to show.

CANADY HELIOS COLD PLASMA ›

CANADY HYBRID PLASMA ›

OUR TREATMENT ›

SCIENCE OF PLASMA ›

ABOUT US ›

OUR PATIENTS ›

NEWS & MEDIA ›

CONTACT USMI ›

Copyright © 2025 US Medical Innovations